Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cost-ineffectiveness of serum vancomycin levels.

Literature DB >> 17534676

Cost-ineffectiveness of serum vancomycin levels.

B A Cunha¹, S S Mohan, N Hamid, B P McDermott, P Daniels.

Abstract

Entities: Chemical

Mesh：

Substances：
Vancomycin
Creatinine

Year: 2007 PMID： 17534676 DOI： 10.1007/s10096-007-0314-4

Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN： 0934-9723 Impact factor: 3.267

× No keyword cloud information.

14 in total

1. Once-daily versus twice-daily intravenous administration of vancomycin for infections in hospitalized patients.

Authors: Eytan Cohen; Alexander Dadashev; Moshe Drucker; Zmira Samra; Ethan Rubinstein; Moshe Garty
Journal: J Antimicrob Chemother Date: 2002-01 Impact factor: 5.790

2. Routine monitoring of serum vancomycin concentrations: waiting for proof of its value.

Authors: D J Edwards; S Pancorbo
Journal: Clin Pharm Date: 1987-08

Review 3. Vancomycin and the kidney.

Authors: G B Appel; D B Given; L R Levine; G L Cooper
Journal: Am J Kidney Dis Date: 1986-08 Impact factor: 8.860

Review 4. Serum vancomycin concentrations: reappraisal of their clinical value.

Authors: T G Cantú; N A Yamanaka-Yuen; P S Lietman
Journal: Clin Infect Dis Date: 1994-04 Impact factor: 9.079

5. Monitoring vancomycin therapy.

Authors: M J Rybak; S C Boike
Journal: Drug Intell Clin Pharm Date: 1986-10

Review 6. Pharmacokinetic optimisation of vancomycin therapy.

Authors: W G Leader; M H Chandler; M Castiglia
Journal: Clin Pharmacokinet Date: 1995-04 Impact factor: 6.447

7. Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice.

Authors: L S Elting; E B Rubenstein; D Kurtin; K V Rolston; J Fangtang; C G Martin; I I Raad; E E Whimbey; E Manzullo; G P Bodey
Journal: Cancer Date: 1998-12-15 Impact factor: 6.860

8. Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity.

Authors: William Darko; Joseph J Medicis; Adrienne Smith; Roy Guharoy; David E Lehmann
Journal: Pharmacotherapy Date: 2003-05 Impact factor: 4.705

Cost-ineffectiveness of serum vancomycin levels.

1. Once-daily versus twice-daily intravenous administration of vancomycin for infections in hospitalized patients.

2. Routine monitoring of serum vancomycin concentrations: waiting for proof of its value.

Review 3. Vancomycin and the kidney.

Review 4. Serum vancomycin concentrations: reappraisal of their clinical value.

5. Monitoring vancomycin therapy.

Review 6. Pharmacokinetic optimisation of vancomycin therapy.

7. Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice.

8. Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity.

9. Effects of antibiotic-diuretic interactions in the guinea pig model of ototoxicity.

10. Vancomycin therapy in patients with impaired renal function: a nomogram for dosage.

1. Predictability of vancomycin pharmacokinetics in neonates.

2. A specially tailored vancomycin continuous infusion regimen for renally impaired critically ill patients.